Brand names
Hyaluronidase (human recombinant) and Ocrelizumab brand names
1 brands in 1 markets
Hyaluronidase (human recombinant) and Ocrelizumab is sold under 1 brand names in 1 markets in our register data, including Ocrevus Zunovo. The table shows the market, marketing authorisation holder, strengths and forms for each brand, with the register it comes from.
| Brand | Market | Marketing authorisation holder | Strengths and forms | Source |
|---|---|---|---|---|
| Ocrevus Zunovo | United States | Genentech | 23000 units/920 mg per 23 mLInjection | US FDA NDC directoryChecked 12 November 2026 |
Brand names and trademarks belong to their owners and are used only to identify products.
Request Hyaluronidase (human recombinant) and Ocrelizumab for export supply
Tell us the strength, quantity and destination country. Our team replies with availability, lead time and the import documents needed.